Overcoming Illiquidity in OTC Markets

When over-the-counter markets are suffering from a limited liquidity supply, buy-side firms can struggle with price formation and counterparty selection; Lee Bartholomew, head of derivatives product R&D in fixed income at Eurex, outlines the strategies and skills that traders should consider when assessing instrument selection.